The Suppressive Effect of Butyrate and Bromopyruvate on Inflammatory Cytokine Production and Short Chain Fatty Acid Receptor Expression by Blood Mononuclear Cells in Patients with Behçet's Disease

BACKGROUND: Controlling inflammation is a therapeutic goal of various autoimmune/autoinflammatory diseases including Behçet's disease (BD). The immunomodulatory effect of metabolites or metabolic analogs such as butyrate and 3-bromopyruvate has been observed in animal disease models. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Su Jin, Kim, Kyongmin, Lee, Eun-So, Park, Sun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992490/
https://www.ncbi.nlm.nih.gov/pubmed/33911480
http://dx.doi.org/10.5021/ad.2018.30.5.566

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7992490/
https://www.ncbi.nlm.nih.gov/pubmed/33911480
http://dx.doi.org/10.5021/ad.2018.30.5.566

Ejemplares similares